World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
14996
World Ranking
2443
National Ranking
96

Overview

Leendert A. Trouw is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily spans the fields of medicine and immunology and microbiology, with notable contributions to subfields such as immunology, rheumatology, radiology, nuclear medicine and imaging, infectious diseases, and hepatology.

The main topics of their scientific work include:

  • Monoclonal and Polyclonal Antibodies Research
  • Complement system in diseases
  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Liver Diseases and Immunity
  • Glycosylation and Glycoproteins Research
  • Platelet Disorders and Treatments

Leendert A. Trouw has published extensively in well-known journals. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Immunobiology
  • Arthritis Research & Therapy
  • RMD Open
  • Proceedings of the National Academy of Sciences

The scientist has collaborated repeatedly with various colleagues. Frequent co-authors are:

  • Douwe J. Dijkstra
  • René E. M. Toes
  • Thomas H. Sharp
  • Kyra A. Gelderman
  • T. Huizinga

Recent significant publications by Leendert A. Trouw include:

  • Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19, 2021, Nature Immunology
  • Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains, 2023, Nature Communications
  • Circulating C1q levels in health and disease, more than just a biomarker, 2021, Molecular Immunology
  • PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation, 2022, Proceedings of the National Academy of Sciences
  • The role of complement activation in autoimmune liver disease, 2020, Autoimmunity Reviews

Best Publications

  • Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage

    Jing Shi;Rachel Knevel;Parawee Suwannalai;Michael P. van der Linden

  • Production of complement components by cells of the immune system

    R Lubbers;M F van Essen;C van Kooten;L A Trouw

  • Complement activation and inhibition: a delicate balance.

    A. P. Sjoberg;L. A. Trouw;Anna Blom

  • Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.

    Alma J. Nauta;Leendert A. Trouw;Mohamed R. Daha;Odette Tijsma

  • Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.

    Helen Benham;Helen Benham;Hendrik J. Nel;Soi Cheng Law;Ahmed M. Mehdi

  • Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis

    Yoann Rombouts;Ewoud Ewing;Lotte A van de Stadt;Maurice H J Selman

  • Anti–cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

    L. A. Trouw;E. M. Haisma;E. W. N. Levarht;D. van der Woude

  • Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes

    Leendert A. Trouw;Tom W.L. Groeneveld;Marc A. Seelen;Jacques M.G.J. Duijs

  • Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population

    Mariana Gaya de Costa;Felix Poppelaars;Felix Poppelaars;Cees van Kooten;Tom Eirik Mollnes;Tom Eirik Mollnes;Tom Eirik Mollnes

  • The influence of ACPA status and characteristics on the course of RA

    Annemiek Willemze;Leendert A. Trouw;René E. M. Toes;Tom W. J. Huizinga

  • Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis

    Jing Shi;Lotte A van de Stadt;E W Nivine Levarht;Tom W J Huizinga

  • Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid

    Hans U. Scherer;Diane van der Woude;Andreea Ioan-Facsinay;Hanane el Bannoudi

  • Anti-Carbamylated Protein Antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis

    Jing Shi;Lotte A. van de Stadt;E. W. Nivine Levarht;Tom W. J. Huizinga

  • The complement system as a potential therapeutic target in rheumatic disease

    Leendert A. Trouw;Matthew C. Pickering;Anna M. Blom

  • Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis

    Yoann Rombouts;Annemiek Willemze;Joyce J B C van Beers;Jing Shi

  • Role of complement and complement regulators in the removal of apoptotic cells.

    L. A. Trouw;A. M. Blom;Philippe Gasque

  • Complement activation by (auto-) antibodies.

    Nina A. Daha;Nirmal K. Banda;Anja Roos;Frank J. Beurskens

  • Maturation of dendritic cells abrogates C1q production in vivo and in vitro.

    Giuseppe Castellano;Andrea M. Woltman;Andrea M. Woltman;Alma J. Nauta;Alma J. Nauta;Anja Roos;Anja Roos

  • The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells

    Andreas P. Sjöberg;Leendert A. Trouw;Simon J. Clark;Jonatan Sjölander

  • Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation

    Wei Xu;Stefan Berger;Leendert Trouw;Hetty de Boer

Frequent Co-Authors

René E. M. Toes
René E. M. Toes Leiden University Medical Center
Tom W. J. Huizinga
Tom W. J. Huizinga Leiden University Medical Center
Anna M. Blom
Anna M. Blom Lund University
Mohamed R. Daha
Mohamed R. Daha Leiden University
Cees van Kooten
Cees van Kooten Leiden University Medical Center
Anja Roos
Anja Roos Leiden University Medical Center
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Peter A. van Veelen
Peter A. van Veelen Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related nursing and healthcare degrees can open up diverse career opportunities. Many professionals choose to enhance their credentials through specialized paths like Nurse Practitioner certifications. For example, pursuing the acute care nurse practitioner certification allows nurses to work in high-demand settings such as intensive care units and emergency departments.

Accelerated programs are popular among those with a background in science or healthcare who wish to quickly transition into advanced nursing roles. An accelerated FNP program offers a streamlined route to becoming a Family Nurse Practitioner, balancing speed and comprehensive training.

For individuals without a nursing background, there are excellent options for starting fresh. High-quality online nursing programs for non nurses provide accessible pathways to enter the nursing profession, combining flexibility with rigorous coursework.

Compensation is also a key consideration. Understanding the DNP salary variation by location can help professionals make informed decisions about where to study and work, maximizing their career potential in the healthcare field.

Best Scientists Citing Leendert A. Trouw

Trending Scientists

Recently Published Articles